End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.89 CNY | +0.45% | +2.92% | +13.94% |
Jun. 06 | Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic | RE |
Jun. 06 | Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China | RE |
Evolution of the average Target Price on Livzon Pharmaceutical Group Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- 000513 Stock
- Consensus Livzon Pharmaceutical Group Inc.